Your Followed Topics

2.8M est. views
health1d ago

Breakthrough melanoma vaccine would slash risk of the deadly cancer returning

Breakthrough melanoma vaccine would slash risk of the deadly cancer returning Open in Independent.co.uk
Highlights
  • In a phase 2 trial, the personalized mRNA melanoma vaccine added to pembrolizumab cut the five-year recurrence risk in high-risk, surgically resected melanoma.
  • About 70% of patients in the vaccine group remained cancer-free at five years, compared with about 49% on standard therapy, suggesting meaningful benefit when paired with pembolizumab.
  • Combining the vaccine with Keytruda reduced the risk of metastasis by about 60%, indicating stronger systemic control of cancer spread.

Virality Score Timeline

Vote 22
0

References

A personalized vaccine for melanoma cut the risk of cancer returning after five years

A personalized vaccine for melanoma cut the risk of cancer returning after five years

A cancer vaccine made just for you. mRNA is back and it's fighting melanoma

A cancer vaccine made just for you. mRNA is back and it's fighting melanoma

Could cancer vaccines be next? New treatment cuts melanoma risk by nearly 50%

Could cancer vaccines be next? New treatment cuts melanoma risk by nearly 50%

Related Topics

0 Comments

Be the first to comment

Add your thoughts and get the conversation going.

Top 675 Internet News Today

Explore Your Interests

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access
Personalized Feed
Full Experience
or
By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Advertisement

Advertisement